IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,815 | -24.0% | 13,366 | +17.6% | 0.00% | -25.0% |
Q2 2023 | $80,038 | +37.4% | 11,369 | +24.7% | 0.00% | +33.3% |
Q4 2022 | $58,270 | -33.3% | 9,119 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $87,360 | -13.2% | 9,119 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $100,674 | +3.8% | 9,119 | +79.4% | 0.00% | +300.0% |
Q4 2021 | $97,015 | -21.9% | 5,082 | +0.8% | 0.00% | -50.0% |
Q3 2021 | $124,286 | -60.8% | 5,040 | -49.7% | 0.00% | -60.0% |
Q1 2021 | $317,012 | -34.7% | 10,013 | -4.3% | 0.01% | -28.6% |
Q4 2020 | $485,530 | +38.3% | 10,464 | -1.9% | 0.01% | +16.7% |
Q3 2020 | $351,191 | +19.1% | 10,668 | -0.7% | 0.01% | +20.0% |
Q2 2020 | $294,950 | -72.2% | 10,745 | -69.7% | 0.01% | -78.3% |
Q1 2020 | $1,061,615 | +4.9% | 35,464 | -3.0% | 0.02% | +35.3% |
Q4 2019 | $1,011,925 | +49.3% | 36,558 | -1.8% | 0.02% | +54.5% |
Q3 2019 | $677,768 | -21.9% | 37,240 | +5.2% | 0.01% | -26.7% |
Q2 2019 | $867,640 | +157.8% | 35,385 | 0.0% | 0.02% | +150.0% |
Q1 2019 | $336,511 | +7.5% | 35,385 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $313,157 | +1.7% | 35,385 | +29.3% | 0.01% | +20.0% |
Q3 2018 | $307,969 | – | 27,375 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |